Add to Favourites
To login click here
The global sanger sequencing market is expected to reach USD 10,130.6 million by 2031, with a CAGR of 18.2% between 2024 and 2031. This growth is driven by increasing demand for nucleic acid sequencing, advancements in technology, and rising prevalence of chronic diseases. The integration of AI and machine learning with Sanger sequencing instruments is a key trend in the market.